The history of the PharmaNutra Group

The history of the PharmaNutra Group was founded from the vision of two brothers, Andrea and Roberto Lacorte, who, in the early 2000s, decided to put together their scientific and commercial insights to change the way people approach health and well-being.

Our commitment

The PharmaNutra Group is currently one of the most appreciated Italian companies in the pharmaceutical and nutraceutical sector, thanks to products made with innovative and patented technologies. A forward-looking business, strengthened by a continuous and increasingly intense Research & Development activity and a constant overseas expansion. A business capable of growing and establishing itself also in the field of sport, through sponsorships of excellence, with the full awareness that at the base of every company, there must be strong financial soundness.

“PharmaNutra was founded from a dream: that of improving personal well-being starting from the properties of the micro- and macronutrients consumed through diet. We have truly believed in this, we have taken risks, we staked everything on our intuitions and on a method of our own. And we will continue to do so.”

Andrea and Roberto Lacorte, Founders of PharmaNutra S.p.A.

Our milestones

2000
Alesco

Establishment of a new company specialised in nutraceutical raw materials.

2003
PharmaNutra

PharmaNutra is founded, for the development of medical devices and nutraceutical products.

2005
SiderAL®

Launch of the company’s first proprietary brand on the market.

2008
New strategic plan

PharmaNutra opens to external investors to launch a new development plan.

2010
Junia Pharma

Establishment of a new company focusing on the paediatric sector.

2013
International distribution

Signature of the first foreign distribution contract.

2014
Elite

PharmaNutra enters the Borsa Italiana Elite programme to consolidate and accelerate its growth.

2016
Awards

The SiderAL® r.m. patent is voted “Readers Ingredient of the Year” by the scientific journal Nutraingredients.

2017
AIM Italia

The PharmaNutra Group is listed on the AIM market of the Italian Stock Exchange, through the innovative pre-booking company IPO Challenger® promoted by Electa.

2019
Top Seller

SiderAL® Forte 20 capsule is the best-selling nutritional supplement in Italy (Federsalus-IQVIA data).

2020
STAR

The PharmaNutra Group moves to the STAR segment of the MTA market.

2023
New HQ site

The new offices will hold one of the most innovative molecular biology laboratory in Europe.